UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

ATTR amyloidosis drug pipeline: silencers & stabilizers

Source
Patsnap

Transthyretin amyloidosis is driving intensive pharmaceutical IP activity across four mechanistically distinct modalities — RNAi silencing, small-molecule stabilization, antibody immunotherapy, and CRISPR gene editing. This analysis maps the patent landscape, identifies the dominant assignees, and highlights combination strategies emerging as the next frontier in ATTR treatment.